HLA – B8 B*08 Test
Test Name: HLA – B8 B*08 Test
Components: 4 mL (3 mL min.) whole blood in 1 Lavender Top (EDTA) tube OR 6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube. Ship refrigerated. DO NOT FREEZE.
Price: 1010.0 AED
Report Delivery: 10-12 days
Method: Reverse SSOP – Luminex
Test Type: Disease Association
Doctor: Physician
Test Department: Pre Test Information
No special preparation required
Test Details
The HLA-B8 (B*08) test is a genetic test that determines the presence or absence of the HLA-B8 gene variant. HLA-B8 is a specific human leukocyte antigen (HLA) gene that plays a role in the immune system’s ability to recognize and respond to foreign substances, such as viruses or bacteria.
The test is typically performed to identify the HLA-B8 gene variant in individuals for various reasons, including:
- Organ transplantation: HLA matching between the donor and recipient is crucial for successful organ transplantation. Identifying the presence of HLA-B8 can help determine the compatibility between the donor and recipient.
- Autoimmune diseases: Certain autoimmune diseases, such as Graves’ disease and myasthenia gravis, have been associated with the presence of the HLA-B8 gene variant. The test can be used to assess the risk of developing these conditions.
- Susceptibility to infections: The HLA-B8 gene variant has been linked to an increased susceptibility to certain infections, such as Epstein-Barr virus (EBV) and HIV. Testing for HLA-B8 can help identify individuals who may be more susceptible to these infections.
The HLA-B8 test is typically performed using a blood sample. The sample is analyzed in a laboratory using techniques such as polymerase chain reaction (PCR) or sequencing to detect the presence or absence of the HLA-B8 gene variant.
It is important to note that the HLA-B8 test is just one component of a comprehensive HLA typing panel, which includes other HLA genes such as HLA-A, HLA-B, and HLA-DR. The combination of these genes provides a more accurate assessment of an individual’s immune system compatibility and disease susceptibility.
Test Name | HLA – B8 B*08 Test |
---|---|
Components | |
Price | 1010.0 AED |
Sample Condition | 4 mL (3 mL min.) whole blood in 1 Lavender Top (EDTA) tube OR6 mL (3 mL min.) whole blood in 1 Yellow Top (ACD) tube. Ship refrigerated. DO NOT FREEZE. |
Report Delivery | 10-12 days |
Method | Reverse SSOP – Luminex |
Test type | Disease Association |
Doctor | Physician |
Test Department: | |
Pre Test Information | No special preparation required |
Test Details |
The HLA-B8 (B*08) test is a genetic test that determines the presence or absence of the HLA-B8 gene variant. HLA-B8 is a specific human leukocyte antigen (HLA) gene that plays a role in the immune system’s ability to recognize and respond to foreign substances, such as viruses or bacteria. The test is typically performed to identify the HLA-B8 gene variant in individuals for various reasons, including: 1. Organ transplantation: HLA matching between the donor and recipient is crucial for successful organ transplantation. Identifying the presence of HLA-B8 can help determine the compatibility between the donor and recipient. 2. Autoimmune diseases: Certain autoimmune diseases, such as Graves’ disease and myasthenia gravis, have been associated with the presence of the HLA-B8 gene variant. The test can be used to assess the risk of developing these conditions. 3. Susceptibility to infections: The HLA-B8 gene variant has been linked to an increased susceptibility to certain infections, such as Epstein-Barr virus (EBV) and HIV. Testing for HLA-B8 can help identify individuals who may be more susceptible to these infections. The HLA-B8 test is typically performed using a blood sample. The sample is analyzed in a laboratory using techniques such as polymerase chain reaction (PCR) or sequencing to detect the presence or absence of the HLA-B8 gene variant. It is important to note that the HLA-B8 test is just one component of a comprehensive HLA typing panel, which includes other HLA genes such as HLA-A, HLA-B, and HLA-DR. The combination of these genes provides a more accurate assessment of an individual’s immune system compatibility and disease susceptibility. |